Back to Journal

SM Ophthalmology Journal

Custom-Q vs Wavefront Optimized Lasik Ablation Treatment Profile in High Myopic Asian Eyes

[ ISSN : 3068-0743 ]

Abstract Citation Introduction Materials and Methods Results Discussion References
Details

Received: 08-Mar-2018

Accepted: 17-Apr-2018

Published: 20-Apr-2018

Elsa LC Mai¹, Iebin Lian², Chih-Cheng Lin³ and Chaokai Chang⁴*

¹Far Eastern Memorial Hospital, Taiwan, ROC
²National Changhua University of Education, Taiwan, ROC
³Yuanpei University of Medical Technology, Taiwan, ROC
?Taipei Nobel Eye Clinic, ROC

Corresponding Author:

Chaokai Chang, Taipei Nobel Eye Clinic, Taiwan ROC, Email: chaokai@nobelgroup.com.tw

Keywords

Myopia; Eye aberrations; LASIK; Keratoconus; Visual acuity; Asphericity; Presbyopia

Abstract

Purpose: To compare the change in asphericity and other Higher Order Aberration (HOA) in Custom-Q vs. Wavefront Optimized (WFO) LASIK ablation profile patients in an Asian population.

Setting: Prospective matched-cohort study in refractive center.

Method: Thirty-four eyes of 17 patients with myopia seeking laser correction at Nobel Clinic in Taipei, Taiwan were enrolled in a prospective cohort study. Utilizing the latest WaveLight®EX500 Excimer Laser (Alcon, Inc., Switzerland), each patient received both Custom Q (CQ) and WFO LASIK ablation treatments (CQ on OD and WFO on OS). Each patient was measured thrice, as follows: (1) Before the Lasik procedure, (2) 1 week after the procedure, and (3) 1 month after the procedure.

Results: The custom-Q ablation group comprised a mean SE of -5.32 diopter (D), and the WFO ablation group comprised a mean SE of -5.41 diopter (D). Their frequencies with which Custom-Q and WFO achieved postoperative Uncorrected Distance Visual Acuity (UCDVA) were not statistically different from each other (P>0.05). No statistically significant differences were found in contrast sensitivity, astigmatism, coma, and trefoil. However, the change of spherical aberration was higher in the WFO ablation profile. Patient questionnaire shows a mild preference for Custom-Q over WFO.

Conclusion: Custom-Q and WFO LASIK provided similar results in myopic refractive correction and achieved post op UCDVA and contrast sensitivity. However, Custom-Q produced less changes in asphericity and HOA changes; Asian patients showed marginal preference for Custom-Q in terms of optic quality.

Citation

Mai ELC, Lian I, Chih-Cheng L and Chang C. Custom-Q vs Wavefront Optimized Lasik Ablation Treatment Profile in High Myopic Asian Eyes. SM Opthalmol J. 2018; 4(1): 1013.

Introduction

Cornea Refractive surgery depends on the change of surface curvature to implement a new eye refractive status. Aberration is introduced when attempts are made to change the surface. One such aberration was Spherical Aberration (SA). Cornea SAs stay constant throughout life, whereas the lens introduces a progressive increase in SA with increasing age. SAs are perceived as halos around lights, and cause glare symptoms. Glare halos and dysphotopsia are the most frequent complaints of patients after LASIK surgery. Glare and halos affect vision quality and induce a loss of low light contrast sensitivity [1]. Therefore, patients would benefit if we avoid introducing more SA during refractive surgery. With the introduction of an aberrometer, Higher Order Aberrations (HOAs) can be measured in patients and subsequently treated. These HOAs most frequently include spherical aberration. Cornea and trifoil treatments for these HOAs evolve with different protocols. Wavefront-Guided (WFG) treatment aims to address all HOA, whereas wavefront-optimized WFO only treats the SA.

As WFG treatment treats all HOAs, it is time consuming to gather all HOA data. Another problem in treating all HOAs is that it involves treating a large amount of cornea, there by leaving the patient with a thinner corneal. Therefore, only eliminating the SA is considered beneficial for some patients. However, we have yet to find out the extent of SA treatment. The wave light allegretto (wave light AG enlarger Germany) Excimer laser provides two different treatment models. As for surgeon adjustment, we adjusted for patients’ original pre-surgical SA, because theoretically, this will induce less change to the eye and produce more patient satisfaction.

To describe the SA or a sphericity of the cornea surface, the wave light Allegretto system used Q-values. A negative Q-value describes a prolate surface, whereas a positive Q value describes an oblate surface [2].

Our study aimed to compare the WFO model vs. CQ model of the wave light Allegretto system.

This study is similar to an evaluation of a one-size-fits-all SA or a customized SA according to the patient’s original data. In the CQ model, the intended Q shift (Q target) was set for the Q value that the patient has on their pre-op Q value. The laser model claimed to change the aspherical by adjusting the number of mid-peripheral laser pulses [3]. By evaluating Q value, SA Total, HOA and third order HOA, and pre and post operation data, we aimed to compare the differences in these two laser models.

In refractive surgical procedure, e.g., femto-assisted LASIK (SMILE), we aimed for a target result with zero High Order Aberrations (HOAs). However, in cataract surgery, we are starting to use trifocal Intraocular Lenses (IOLs), which are IOLs that provided some working vision for people with near, intermediate, and far vision. Most of the time, the ophthalmology surgeon determines the needs and wants of the patients, i.e., some wanted near vision, whereas others wanted far vision. Some working class patients wanted intermediate computer screen vision. One patient insisted on IOL with an end point of -2.0D for his long hours of computer use; he was willing to sacrifice his far distant vision (for driving), because he does not need to drive all the time. Such decisions require guess work and interview with the patients. If the decision is wrong, patients are not happy with the results.

The wavefront optimized ablation has an aspheric profile in which the amount of asphericity is not adjustable. Similarly, the Custom-Q ablation is also an aspheric ablation, but it considers the ability of the surgeon to define the intended Q-shift by specifying a desired asphericity target.

Stojanovic et al. [2] compared the performance between WFO and custom-Q by using two independent samples, and the difference in postoperative change in Q-values with marginal significance (P=0.049) was found, but no such difference was found in HOAs, low contrast visual acuity, or classic outcome parameters. Considering the improvement in LASIK equipment, would WFO still have an advantage over Custom-Q? The aim of this study is to compare the performance between WFO treatment and Custom-Q treatment under the latest WaveLight®EX500 Excimer Laser (Alcon, Inc., Switzerland). To avoid the between-individual variation, we designed a pairwise comparison study by applying both treatments on the same patient (Custom-Q on OD and WFO on OS).

Materials and Methods

Thirty-four eyes of 17 patients with myopia seeking laser correction at Nobel Clinic in Taipei, Taiwan were enrolled in a prospective cohort study. Inclusion criteria were as follows: Aged 20 years old or older; did not use contact lens for 2 weeks before baseline examination; and manifested refraction spherical equivalent between -1.0 and -10.0 diopters (D) with <-3.50D of refractive astigmatism. Exclusion criteria were keratoconus or keratoconus suspect and previous eye surgery.

Utilizing the latest WaveLight®EX500 Excimer Laser (Alcon, Inc, Switzerland), each patient received both Custom Q and WFO LASIK ablation treatments (CQ on OD and WFO on OS). The target refraction in all eyes was emmetropia. Manifest refraction, adjusted with a modified manufacturer’s nomogram, was used as the programming basis of all treatment. LASIK flaps were created using the 150kHz Intra Lasei FS (Abbott Medical Optics, Santa Ana, CA). Main outcome measure parameters included residual refractive error, Uncorrected Distance Visual Acuity (UCDVA), contrast sensitivity, Q-value asphericity, HOAs, and subjective patient optic quality questionnaire. Each patient was measured thrice in the same refractive center, as follows: (1) Before the Lasik procedure, (2) 1 week after the procedure, and (3) 1 month after the procedure.

Zernike polynomial divided the eye aberrations into high and low. Low order aberrations are defocus ones, such as myopia, hyperopia, astigmatism, and presbyopia. High order aberrations have relatively unfamiliar names, such as coma(z31), trefoil(z33), spherical aberration(z40), Wavefront diameter (in mm),and Wavefront HOAs. T hey were calculated by using Zernike polynomial with unit as root mean square and were denoted as Coma_Z31, Trefoil_Z33, Sph_ Aberration_Z40, WF_Diam, and WF_HOA, respectively in Table 1

Table 1: Three measurements on OD and OS from 17 patients: Before procedure, 1 week after the procedure, and 1 month after procedure.

 

 

Before

One-week-after

One-month-after

 

Mean

Std

Mean

Std

Mean

Std

Age (All, N=17)

 

31.412

6.135

-

-

-

-

Age (Female, N=11)

 

30.909

6.316

-

-

-

-

Age (Male, N=6)

 

32.333

6.25

-

-

-

-

 

Q-value

OD

-0.268

0.119

1.007

0.914

1.192

0.681

OS

-0.283

0.131

0.788

0.971

1.071

0.828

 

WF_Diam_mm

OD

5.614

0.504

5.638

0.681

5.359

0.639

OS

5.625

0.759

5.5

0.688

5.344

0.806

 

WF_High_Orde_Aberr

OD

0.282

0.134

0.472

0.205

0.391

0.139

OS

0.293

0.149

0.446

0.177

0.399

0.222

 

Coma_Z31

OD

0.155

0.093

0.299

0.216

0.246

0.135

OS

0.161

0.116

0.273

0.193

0.274

0.199

 

Trefoil_Z33

OD

0.152

0.092

0.195

0.09

0.174

0.074

OS

0.148

0.085

0.177

0.075

0.151

0.095

 

Sph_Aberration_Z40

OD

0.082

0.097

0.068

0.192

0.015

0.136

OS

0.063

0.131

0.019

0.201

0.003

0.182

The 1 week improvements in Q-value due to procedure on each eye were measured according to the increments between the measurements before and 1 week after the procedure (diff_1_ week). The 1 month improvement was the difference between the measurement before and 1 month after the procedure (diff_1_month). We then compared the performance of CQ and WFO according to their 1week improvements, which were measured by the difference between the 1 week improvements of OD and OS: OD(diff_1_week) OS(diff_1_week); and the one-month-improvements: “OD(diff_1_ month)-OS(diff_1_month)” respectively. We used Wilcox on Signed Rank Test to compare the differences to cope with the small sample size and the dependency between the paired data of OD and OS.

Results

Seventeen patients’ completed the measurements on both OD and OS for the three stages. The average age is 31.57 years old, with no difference between genders. The initial averaged Q-values (Table 1, column 3) of OD and OS were -0.268 and -0.283, respectively. Other initial measurements of OD and OS were 5.614 and 5.625 for WF_Diam_mm, 0.282 and 0.293 for WF_High_Orde_Aberr, and 0.155 and 0.161 for Coma_Z31. Pairwise t-tests indicated that the initial measurements between OD and OS showed no difference. At 1week after the treatment, the Q-values increased to 1.007 and 0.788. After 1month, they further increased to 1.192 and 1.071, respectively. Figure 1 compares the secular trends between OD and OS, on Q-value, Wavefront diameter in mm, Wavefront high order aberrations, Trefoil_z33, Coma_z31, and Spherical aberration_z40. Figure-1a shows obvious improvements (increments) of on Q_value 1week or 1month after LASIK procedures of both OD and OS; this result was expected. Figures -1c and -1e also show an increase in Wavefront HOAs andComa_Z31 after surgery. Trefoil_Z33 showed no obvious change after surgery (Figure 1d). Wavefront diameter in Figure-1b and Sph_Aberration_Z40 in Figure-1f decreased after surgery.

Figure 1: Comparison of secular trends between OD and OS, on Custom-Q (1a), Wavefront diameter in mm (1b), Wavefronthigh order aberrations (1c),trefoil_z33 (1d), coma_z31 (1e), and spherical

We used Wilcoxon Signed Rank Tests to compare the difference in improvement between OD and OS. Table 2 shows that Custom-Q had significantly better short-term (1week after procedure) improvement than WFO (p-value=0.027). However, for the longer term (1month after), the deviance diminished to less than half (p-value=0.268). Further analysis on each of the 5 major HOA components (WF_ Diam_mm, WF_High_Orde_Aberr, Coma_Z31, Trefoil_Z33, and Sph_Aberration_Z40) showed no significant difference between CQ and WFO.

Table 2: Wilcoxon signed rank tests on the examination of differences in Q-value and HOA components improvement between CQ (OD) and WFO (OS)

 

Wilcoxon Signed Rank Test

Diff_1_week

Diff_1_month

Mean

Std

p-value

Mean

Std

p-value

Q-value

0.223

0.513

0.027

0.057

0.407

0.268

WF_Diam_mm

0.202

0.82

0.053

0.111

0.671

0.536

WF_High_Orde_Aberr

0.042

0.164

0.361

0.026

0.208

0.587

Coma_Z31

0.036

0.201

0.448

0.014

0.122

0.766

Trefoil_Z33

0.014

0.089

0.7

0.001

0.1

0.495

Sph_Aberration_Z40

0.05

0.131

0.134

-0.002

0.221

0.966

Discussion

Some researchers concluded that wavefront-guided customized ablation produced better results [4]. Researchers accepted that HOA has a significant role in the worsening of visual quality of all the HOAs, SA is the most common. The refractive surgery ablation profile itself will induce SA. Therefore, a treatment for SA (along with the refraction correction) is imminent. However, the amount of correction for SA has been in question. Stojanoniz et al [2] showed that CQ ablation results include a mean post-operation asphericity closer to the pre-operative status as compared with WFO, but the difference was only marginally statistically significant (P=0.049).

The Q-Target was not reached, even though the Q Target was set at double the WFO Q target (-0.6 vs. -0.3) [2]. With increasing myopic correction, the ablation profile results in an increasingly oblate (more Q plus) condition. WFO profile uses a target Q-value that is universal, and the value is obtained from the average value of a population database. By contrast, CQ profile allows the surgeon to set a target Q value. In our case, we chose the pre-op data with Q value as the Target Q. Therefore, comparing CQ and WFO, CQ is small compared with a standard deviations database with WFO as the mean database.

In our study, we aimed to lower inter-personal difference by comparing the Left and Right eye in a same day treatment procedure, based on the fact that the two eyes are most likely mirror images of one another. Considering that CQ treatment uses up more cornea tissue, we used CQ on thicker cornea and WFO on thinner cornea. In results, the custom-Q ablation group comprised a mean SE of -5.32 diopter, and the WFO ablation group comprised a mean SE of -5.41 diopter. The frequency at which Custom-Q and WFO achieved postoperative UCDVA were not statistically different from each other (P>0.05). There were neither no statistically significant differences in contrast sensitivity, astigmatism, coma, and trefoil. However, the change of spherical aberration was higher in WFO ablation profile. Patient questionnaire results showed a mild preference for Custom-Q over WFO.

The non-significant difference in satisfactory rate or difference between HOA or any of the refractive data corroborate our assumption that treating all the spherical aberration is not essential. More effort should be aimed at treating all the lower order aberration to obtain the best satisfactory results. Custom-Q and WFO LASIK provided similar results in myopic refractive correction, and achieved post op UCDVA and contrast sensitivity. However, Custom-Q produced less changes in asphericity and HOA changes. Asian patients showed a marginal preference for Custom-Q for optic quality.

Quoting Jack Holliday’s comments [5] on older presbyopic patients: “If they want to depend less on readers, they will benefit from small negative spherical aberration”. It was shown that small negative SAs help expend the depth of field for the patients. Thus, in older presbyopia patients, this might be helpful for their failing near vision, thereby decreasing their dependence on their readers.

References

1. Aslam TM, Haider D, Murray IJ. Principles of disability glare measurement: An ophthalmological perspective. Acta Ophthalmol. Scand. 2007; 85: 354-360.

2. Stojanovic A, Wang L, Jankov MR, Nitter TA, Wang Q. Wavefront optimized versus custom-Q treatments in surface ablation for myopic astigmatism with the WaveLight ALLEGRETTO laser. J Refract Surg. 2008; 24: 779-789.

3. Koller T, Iseli HP, Hafezi F, Mrochen M, Seiler T. Q-factor customized ablation profi1e for the correction of myopic astigmatism. J Cataract Refract Surg. 2006; 32: 584-589.

4. Khalifa MA, Alsahn MF, Shaheen MS, Pinero DP. Comparative analysis of the efficacy of astigmatic correction after wavefront-guided and wavefront optimized LASIK in low and moderate myopic eyes. Int J Ophthalmol. 2017; 10: 285-292.

5. Holladay JT. Spherical Aberration: The Next Frontier, Cataract & Refractive Surgery Today. 2006

Other Articles

Article Image 1

Application of Anti-Scarring Drugs and Drug Delivery Systems in Glaucoma Surgeries

Anti-scarring Drugs And Drug Delivery systems (DDSs) that are more effective and safer than mitomycin C have been sought to improve the outcome of glaucoma filtration surgeries. Drugs that selectively inhibit wound healing, including anti-transforming growth factor-β and anti-vascular endothelial growth factor antibodies, have been investigated, although their advantages are yet to be verified in humans. In addition, novel sustained release DDSs with fewer toxic effects have been studied for application after glaucoma surgeries. Several potential biomaterials for such DDSs, including gelatin hydrogel, have been introduced.

Tetsuya Sugiyama


Article Image 1

Biorbital Lymphoma with Severe Exophthalmos

A 34-year-old man presented with binocular proptosis for half a year and sight lost for seven days. The patient had a facial lymphoma resection and postoperative chemotherapy five years ago.

Dajiang Wang¹ and Boyan Fang²*


Article Image 1

Research Progress and Human Clinical Trials of Mesenchymal Stem Cells in Ophthalmology: A Mini Review

Ocular diseases are devastating as most of them would cause irreversible visual impairment and blindness. Conceptually, cell replacement therapy with new ocular cells generated by ocular stem cells can substitute the degenerated or damaged cells in the diseased tissue. This concept has first been applied in the limbal transplantation by limbal progenitor cells. Unfortunately, patients with limbal stem cell deficiency and the endogenous progenitor cells present in human corneal endothelium as well as retina have limited regenerative power. In recent decades, other stem cell sources for ocular cell regeneration have been explored and are now feasible with the use of pluripotent stem cells, such as the embryonic stem cells (ESCs) and the induced pluripotent stem cells (iPSCs). Nevertheless, autologous transplantation would not be applicable using ESCs, whereas the variability of reprogramming methods as well as genetic instability of iPSCs has hindered their direct applications. Alternatively, human adult stem cells, such as hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs) are found throughout the body and can be efficiently isolated from patients while maintaining the characteristics of self-renewal and multipotency. Superiorly, adult stem cells harness the potential to protect the ocular cells, where MSCs are able to modulate the microenvironments of the diseased eye for neuroprotection. This article compiled the current progress of MSCs in ocular research. Moreover, the updated clinical trials of adult stem cells in ocular diseases are summarized. In addition, potential challenges and future prospects of stem cell research in ophthalmology would also be discussed.

Tsz Kin Ng* and Jasmine Sum-Yee Yung


Article Image 1

Bilateral Extramacular Choroidal Neovascularization in Wet Age-Related Macular Degeneration

Purpose: Choroidal neovascularization is a common complication following several retinal conditions, most commonly age-related macular degeneration (AMD). We present a case of bilateral extramacular choroidal neovascularization in a patient with wet AMD.

Methods/Patients: Interventional Case Report. Clinical, radiologic, and angiographic correlation.

Results: An 89 year old Caucasian male with Age-related Macular Degeneration (AMD) developed bilateral vitreous hemorrhages and subretinal hemorrhages after which were noted bilateral extramacular choroidal neovascular membranes. The vitreous hemorrhage in the left eye cleared on its own, while vitrectomy was performed in the right eye. Bevacizumab (Avastin) was injected into both eyes. Eighteen months after initial presentation and three months after Bevacizumab, the patient was asymptomatic, both neovascular membranes were inactive, and visual acuity had improved to 20/70 OD and 20/100 OS.

Conclusions: We report the first case of aggressive bilateral extramacular choroidal neovascular membranes in a patient with wet AMD. The pathophysiology that causes AMD to target the macula and fovea in most cases, but the extramacular region in this case, has yet to be elucidated.

Natasha A Naik*, Yannis M Paulus and Darius M Moshfeghi 


Article Image 1

Intraocular Lens Power Calculation after Intracorneal Ring Segment Surgery for the Treatment of Post-LASIK Ectasia

Objective: To describe the method of Intraocular lens (IOL) power calculation in eyes after Intracorneal Ring Segment (ICRS) surgery for the treatment of post-LASIK ectasia.

Design: Retrospective observational case-series.

Participants: Three eyes of 2 patients were included in this study.

Methods: Corneal curvature in the central effective optical zone was averaged using corneal topography and k-reading (Kr) was calculated using Jarade IR method for Kr after LASIK. The calculated Kr was used in SRK-T formula for IOL calculation. Accuracy of this IOL calculation method was judged using the manifest refraction outcome after cataract surgery. All eyes were targeted for emmetropia after cataract.

Results: In our series, one eye developed cataract after ICRS surgery for the treatment of ectasia after hyperopic LASIK (+4 D) and 2 eyes developed cataract after ICRS surgery for the treatment of ectasia after myoic LASIK (-10 D). The spherical equivalent of manifest refraction after cataract surgery was within 1.25 D in all eyes.

Conclusion: Using the average corneal curvature in the central effective optical zone to calculate Kr “by Jarade IR” method was found to be accurate in calculating IOL power in ectatic eyes treated by ICRS surgery

Elias Jarade¹#, Ali Dirani¹,²#, Ali Fadlallah MD¹,², Elias Chelala², Henry Fakhoury¹, George Cherfan¹*


Article Image 1

Unilateral Choroidal Osteoma with Choroidal Neovascularization

Purpose: Choroidal osteoma is a rare tumor which features intraocular bone formation. This tumor can be complicated by choroidal neovascularization which is a cause of impaired vision in this condition. We present a case of choroidal osteoma with choroidal neovascularization as a complication.

Methods: Case report with clinical and angiographic correlation.

Results: A 16 year old female presented with a choroidal osteoma in the left eye complicated by choroidal neovascularization. The patient was treated with Bevacizumab; an intravitreal anti-Vascular Endothelial Growth Factor (Anti-VEGF). Following treatment there was improvement in vision as well as resolution of the choroidal neovascular membrane.

Conclusion: We present a case of choroidal osteoma with choroidal neovascular membranes. Subfoveal Choroidal Neovascularization (CNV) associated with choroidal osteoma may be safely treated with bevacizumab. Larger studies are required to fully evaluate the management and long-term outcomes of anti-VEGF therapy for CNV associated with choroidal osteoma.

Courtney M Crawford¹ and Okezie C Igboeli²*


Article Image 1

Retinal Hemorrhage after Infliximab Use

Infliximab is a chimeric monoclonal antibody against Tumor Necrosis Factor-α (TNF-α), initially developed for treatment of rheumatoid arthritis and inflammatory bowel disease

Es Souiri J¹, Abourazzak FE¹, Andaloussi Idrissi B² and Harzy T¹*


Article Image 1

Giant Retinal Tear Retinal Detachment Etiologies, Surgical Outcome and Incidence of Recurrent Retinal Detachment after Silicon Oil Removal

Purpose: To evaluate etiologies, management, and outcomes of patients with Giant Retinal Tears (GRT) undergoing primary surgery at tertiary referral center.

Methods: A Retrospective, consecutive case series of 94 patients with at least 3 months follow up after silicon oil removal. 57 eyes (60.6%) underwent vitrectomy, 36 eyes (38.3%) underwent combined vitrectomy with buckling and 1 eye (1.1%) underwent scleral buckling. Perfluorocarbon (PFCL) heavy liquid to flatten GRT f lap intraoperative has been used then PFCL air exchange then air silicon exchange in all eyes undergoing vitrectomy. Fellow eye was observed for retinal detachment.

Results: Idiopathic cause constitute 47 eyes (50%), 25 eyes (26.6%) are myopic and 22 eyes (23.4%) have history of trauma. 85 eyes (90.4%) achieved anatomic success. Visual acuity at the last follow-up was at least 20/400 in 71 eyes (75.5%) of patients. Recurrent retinal detachment after Silicon Oil Removal (SOR) was found in 21 eyes (22.3%) of which, 50% had Proliferative Vitreoretinopathy Grade C (PVR-C) or more (p value 0.03) and 20% had GRT size more than 180° (p value 0.04). Pars Plana Vitrectomy (PPV) alone (p value 0.89) or combined PPV with buckling (p value 0.98) have no significant correlation with recurrent Retinal Detachment (RD). 21% of the fellow eye had retinal detachment.

Conclusion: Idiopathic cause constitutes the majority 50%. Patients with GRT who underwent surgery achieved high anatomic success rate. PVR-C or more remain the most significant risk factor for recurrent RD after SOR whereas PPV alone or combined PPV with buckling have no significant correlation with recurrent RD.

 

Eman Abo Taleb


Article Image 1

Macular Hole Surgery after Treatment with Ocriplasmin for Full Thickness Idiopathic Macular Holes with Vitreomacular Traction

Purpose: To report the efficacy of Ocriplasmin in the treatment of small-medium sized idiopathic full thickness Macular Holes with focal Vitreomacular traction in comparison with vitreous surgery.

Methods: Retrospective observational single-centre small case series (n=6) studythat included patients who underwent vitrectomy after unsuccessful treatment ofsmall-medium size full thickness Idiopathic macular holes with ocriplasmin.

Results: 6 eyes with full-thickness macular holes and VMT were included, whereby in 4 eyes an epiretinal membrane was present (66.7%). Resolution of VMT after intravitreal injection of ocriplasmin was shown in three out of six eyes (50%) and in all six eyes after vitrectomy (100%). Of all six eyes presenting macular holes with a mean size of 265 µm ± 109 µm at baseline visit, five eyes showed persistent macular holes at the second follow-up visit with a mean size of 335 µm ± 166 µm. After vitrectomy no macular hole could be detected at the f inal follow-up visit.

Conclusion: We present our clinical experience with intravitreous injection of Ocriplasmin to confirm the presumed therapeutic effect in patients suffering from Vitreomacular Traction (VMT) with small-medium sizedfull thickness Macular holes (MH). Small macular holes could frequently be closed with only Ocriplasmin and without surgery with a 17% closure rate. Enlargement in all holes that failed to close with Ocriplasmin was observed in all treated eyes which makes us believe that the VMT could have a Protective role. Ellipsoid zone disruptions were evident in 50% of treated eyes and more common in eyes with successful VMT release. Although data on Ocriplasmin from several studies remain controversial but so far the results are consistent with the results and recommendations of other clinical studies and the European Medicine Agency. We agree that replacing vitrectomy for MHs with one injection of Ocriplasmin would be a very attractive option but so far Pars plana vitrectomy remain the treatment of choice for most eyes with MHs. Further Work is recommended to reveal the Cause of the ellipsoid zone Changes, the mechanisms of tractional forces and to investigate the Long term side effects of Ocriplasmin.

Khaled Helaiwa¹,², Ammar Heider², KU Bartz-Schmidt¹ and Kai Januschowski¹,²*


Article Image 1

Comparing Refractive Outcomes of Standard Phacoemulsification with Femtosecond Laser-Assisted Cataract during the Initial Learning Curve and with More Experience

Purpose: To analyze and compare the refractive outcomes of standard phacoemulsification with femtosecond laser-assisted cataract surgery performed during the initial learning curve and a year later by experienced surgeons.

Methods: This single-center retrospective study was divided into 3 groups: Group 1, 63 patients who underwent standard phacoemulsification (control group) prior to femtosecond laser acquisition by two anterior segment surgeons; Group 2, the first 104 patients who underwent femtosecond laser-assisted cataract surgery by the same surgeons from Feb 19, 2014 to April 30, 2014 (learning curve group) and Group 3,108 patients who underwent femtosecond laser-assisted cataract surgery by the same surgeons a year later from Feb, 2015 until June 30, 2015 (experienced group).

Results: Mean absolute refraction prediction errors were 0.37 ± 0.25 Diopters (D) in the control group, 0.30 ± 0.24 D in the “learning group” and 0.30 ± 0.24 D in the experienced group with no significant differences among groups. The percentages of eyes within 0.5 D of the targeted refraction were 69.8%, 90.5% and 82.5% in the control group, learning group, and experienced group, respectively (p

Conclusion: There was no statistically significant difference in the mean postoperative refraction prediction errors between femtosecond laser-assisted cataract surgery and standard phacoemulsification in either the learning curve or experienced group. However, a higher percentage of patients were within 0.5 D of the targeted refraction in the learning curve femtosecond laser-assisted cataract surgery group compared with the standard phacoemulsification group.

Ildamaris Montes de Oca, Sumitra S Khandelwal, Eric J Kim, Tim Soeken, Ryan Barrett, Li Wang, Mitchell P Weikert, Douglas D Koch and Zaina Al-Mohtaseb*